Innovating Works

UH MOTOL

A stranger
ERDERA: EUROPEAN RARE DISEASES RESEARCH ALLIANCE FAKULTNI NEMOCNICE V MOTOLE participó en un HORIZON EUROPE HORIZON-HLTH-2023-DISEASE-07 The European Rare Diseases Research Alliance (ERDERA) aims to improve the health and well-being of the 30 million people living with a rare...
2024-08-20 - 2031-08-31 | financed
CHARLESTON: CHARLES University Programme for Sustainable Goals Training Openness and Novelty in Research Charleston stands for CHARLES University Programme for Sustainable Goals, Training, Openness and Novelty in Research. It's a unique opportun...
2024-08-20 - 2029-12-31 | financed
Maxima Butterfly: From Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology network FAKULTNI NEMOCNICE V MOTOLE participó en un HORIZON EUROPE HORIZON-MSCA-2021-COFUND-01 Every year, around 600 children in the Netherlands get cancer and one in four children dies from this illness. More than ten years ago, a gr...
2022-10-10 - 2027-12-31 | financed
VISION DMD: VISION DMD Phase 2 Clinical Trials of VBP15 An Innovative Steroid like Intervention on Duchenne M... FAKULTNI NEMOCNICE V MOTOLE participó en un H2020 H2020-PHC-2014-2015 VISION-DMD aims to advance clinical development of the orphan drug VBP15 as a new therapy to revolutionise care for all patients with Duchen...
2015-12-09 - 2021-12-31 | financed
ChiLTERN: Children s Liver Tumour European Research Network FAKULTNI NEMOCNICE V MOTOLE participó en un H2020 H2020-PHC-2014-2015 Liver cancer in the paediatric population is rare with an incidence approximately 1-1.5 per million population. The commonest tumour seen in...
2015-12-07 - 2021-12-31 | financed
NISCI: Antibodies against Nogo A to enhance plasticity regeneration and functional recovery after acute sp... FAKULTNI NEMOCNICE V MOTOLE participó en un H2020 H2020-PHC-2014-2015 Spinal cord injury is a severe and devastating neurological disorder that leaves patients with permanent paralysis of the body. No treatment...
2015-09-11 - 2023-06-30 | financed
EPISTOP: Long term prospective study evaluating clinical and molecular biomarkers of epileptogenesis in a ge... FAKULTNI NEMOCNICE V MOTOLE participó en un FP7 Despite a great progress in the management of epilepsy, still one third of patients is refractory to available medications. The incidence of...
financed
INTREALL: International study for treatment of childhood relapsed ALL 2010 with standard therapy systematic i... FAKULTNI NEMOCNICE V MOTOLE participó en un FP7 Though survival of children with acute lymphoblastic leukaemia (ALL) has improved, relapse remains a leading cause of mortality in childhood...
financed
PANCARELIFE: PanCare Studies in Fertility and Ototoxicity to Improve Quality of Life after Cancer during Childhoo... FAKULTNI NEMOCNICE V MOTOLE participó en un FP7 Survival rates after childhood cancer now reach nearly 80% in developed European countries as a result of more effective therapies and bette...
financed
DISCHARGE: Diagnostic Imaging Strategies for Patients with Stable Chest Pain and Intermediate Risk of Coronary... FAKULTNI NEMOCNICE V MOTOLE participó en un FP7 Coronary artery disease (CAD) is the leading cause of death in high-income countries. Invasive coronary angiography (ICA) is the reference s...
financed
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.